{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:09:43Z","timestamp":1776323383806,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.diabet.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T09:08:31Z","timestamp":1529399311000},"page":"399-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Decreased plasma aldosterone levels in patients with type 2 diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism"],"prefix":"10.1016","volume":"45","author":[{"given":"T.","family":"Anno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hirukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kaneto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2018.06.003_bib0060","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Mini-review: primary aldosteronism-changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2018.06.003_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.diabet.2018.06.003_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/hmbci-2015-0065","article-title":"Aldosterone and type 2diabetes mellitus","volume":"26","author":"Zavatta","year":"2016","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.diabet.2018.06.003_bib0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/diab.23.10.835","article-title":"Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension","volume":"23","author":"Christlieb","year":"1974","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2018.06.003_bib0080","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.1977.03630190020008","article-title":"Hyporeninemia and hypoaldosteronism in diabetes mellitus","volume":"137","author":"Perez","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabet.2018.06.003_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.HYP.3.1.87","article-title":"Low plasma renin activity in normotensive patients with diabetes mellitus: relationship to neuropathy","volume":"3","author":"Ferandez-Cruz","year":"1981","journal-title":"Hypertension"},{"key":"10.1016\/j.diabet.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1253\/jcj.47.49","article-title":"The inactive to active renin ratio in the kidneys and the plasma in diabetic nephropathy","volume":"47","author":"Kawamura","year":"1983","journal-title":"Japan Circ J"},{"key":"10.1016\/j.diabet.2018.06.003_bib0095","first-page":"216","article-title":"Plasma inactive renin in diabetic patients with neuropathy: a role for the sympathetic nervous system in the convertion in vivo of inactive renin","volume":"104","author":"Nakamaru","year":"1983","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.diabet.2018.06.003_bib0100","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM198505303122202","article-title":"Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications","volume":"312","author":"Luetscher","year":"1985","journal-title":"N Engl J Med"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363618301186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363618301186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:55:15Z","timestamp":1761130515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363618301186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1262363618301186"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2018.06.003","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased plasma aldosterone levels in patients with type 2diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}